十一月 2025
- Home
- Arthrosurface
十一月 2025的Arthrosurface市场份额分析
Arthrosurface Motion Preserving Joint Replacement Solutions for patients suffering from joint pain and arthritis | contact@arthrosurface.com
Arthrosurface(包含公司地区分支机构)
查看更多网站流量和参与度信息- arthrosurface.com
Arthrosurface收入截至 十一月 2025为 15M - 25M
Arthrosurface主要域名产生的收入
3 年中Arthrosurface主要域名的收入
Arthrosurface主要域名的收入
Arthrosurface热门域名的总访问量
了解Arthrosurface市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Arthrosurface热门域名的平均访问时长
分析Arthrosurface参与度指标。
过去 3 个月的平均访问时长
子公司明细
Arthrosurface热门域名的平均页面浏览量
了解Arthrosurface如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Arthrosurface 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Arthrosurface, Inc. launched SpiralUp TCL Allograft System on Nov 25th '19.Arthrosurface has launched its SpiralUp TCL Allograft System, which is designed for adult and adolescent patients suffering from talocalcaneal instability, peritalar subluxation, and other injuries resulting in instability in the subtalar joint.
七月 30, 2020阅读更多
新闻Anika Therapeutics, Inc. acquired Arthrosurface, Inc. for $60M on Feb 3rd '20.Anika Therapeutics Inc. announced it has signed agreements to acquire Parcus Medical and Arthrosurface.
一月 7, 2020阅读更多
新闻Anika Therapeutics Inc. acquired Arthrosurface, Inc. for $60M on Jan 6th '20.Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, today announced it has signed agreements to acquire Parcus Medical, a leading, privately-held sports medicine company, and Arthrosurface, a leading, privately-held provider of joint surface and preservation solutions for active patients.
一月 5, 2020阅读更多
查看 Arthrosurface 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。